Published in

Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 3(75), p. 537-546

DOI: 10.1007/s00280-014-2674-7

Links

Tools

Export citation

Search in Google Scholar

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine

Journal article published in 2015 by Edward M. Newman, M. Suzette Blanchard, Robert J. Morgan, Shivaani Kummar, Jan H. Beumer, M. Suzette Blanchard, Christopher Ruel, Anthony B. El Khoueiry, Mary I. Carroll, Jessie M. Hou, Chun Li, Heinz J. Lenz, Julie L. Eiseman, James H. Doroshow
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO